Delcath Systems, Inc. (DCTH) Hit With Another FDA Setback  
5/1/2013 9:17:02 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Delcath Systems, which is moving its headquarters from Manhattan to Queensbury, NY, could be forced to conduct another clinical trial before it receives approval from the U.S. Food and Drug Administration. The medical device company is seeking approval for a liver cancer fighting system. The Post Star of Glens Falls, NY, has the story about the latest delay from the FDA.

Help employers find you! Check out all the jobs and post your resume.